apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma (2020) Toussaint F, Erdmann M, Grosch E, Schliep S, Schuler G, Dummer R, Heinzerling L Journal article, Letter ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer (2020) Fleschutz K, Walter L, Leistner R, Heinzerling L Journal article PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts (2020) Weigert V, Jost T, Hecht M, Knippertz I, Heinzerling L, Fietkau R, Distel L Journal article SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy (2020) Kramer R, Mentzer D, Erdmann M, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel S, et al. Conference contribution Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis (2020) Spassova I, Ugurel S, Zimmer L, Schadendorf D, Terheyden P, Andtback HB, Villabona L, et al. Conference contribution Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation (2020) Zaremba A, Martaki A, Salzmann M, Baroudjian B, Sachse MM, Gesierich A, Reinhardt L, et al. Conference contribution The Quality of Guidelines for the Treatment of Cutaneous Melanoma: A methodological Assessment (2020) Steeb T, Wessely A, Drexler K, Salzmann M, Toussaint F, Heinzerling L, Reinholz M, et al. Conference contribution Detection and Assessment of epidermotropic, pigmented Melanoma Metastases under Therapy using 3D Whole-Body Photography (2020) Erdmann M, Toussaint F, Hornung A, Heinzerling L, Berking C, Schliep S Conference contribution Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts (2020) Garbe C, Keim U, Suciu S, Amaral T, Eigentler TK, Gesierich A, Hauschild A, et al. Journal article Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis (2020) Zhang L, Zlotoff DA, Awadalla M, Mahmood SS, Nohria A, Hassan MZ, Thuny F, et al. Journal article